APOBEC3 activity promotes the survival and evolution of drug-tolerant persister cells during acquired resistance to EGFR inhibitors in lung cancer.

Garcia NMG, Becerra JN, McKinney BJ, DiMarco AV, Wu F, Fitzgibbon M, Alvarez JV
bioRxiv. 2023 Jul 3:2023.07.02.547443. doi: 10.1101/2023.07.02.547443. Preprint. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.